Facebook
X
LinkedIn
ForwardUtilization of a Diagnosis Coding Reference Guide for Anaphylaxis (Non-CME)
Anaphylaxis can be challenging to recognize, document, and code accurately due to its diverse clinical presentations, evolving diagnostic guidance, and the complexity of ICD-10 coding requirements. Incomplete documentation and inconsistent coding practices can affect patient care, prior authorization approvals, reimbursement, and the quality of clinical data used to inform treatment and research.
Join experts David Fleischer, MD, Anna Nowak-Wegrzyn, MD, PhD, and J. Wesley Sublett, MD, MPH as they discuss practical approaches to recognizing anaphylaxis, documenting key clinical findings, and selecting diagnosis codes that accurately reflect the clinical scenario.
Participants receive downloadable resources including a diagnosis coding guide, ACAAI/AAN anaphylaxis at-a-glance, and patient education tools to support clinical decision-making, documentation, coding accuracy, and practice efficiency.
This activity is not certified for CME credit. This webinar is free to members and non-members.
This activity is sponsored by a medical education grant from ARS Pharmaceuticals, Inc.
Target Audience
This activity is intended for allergists, allergy advance practice providers, and primary care providers.
Learning Objectives
After participating in this education, learners should be able to:
- Recognize and accurately identify the clinical signs and symptoms of anaphylaxis, including its various presentations and triggers and document anaphylaxis cases comprehensively and precisely, specifying the cause (e.g., food, medication, insect sting), severity, and encounter type (initial, subsequent, sequela).
- Understand and apply the appropriate ICD-10-CM codes for anaphylaxis, selecting the correct codes based on clinical documentation and coding guidelines and navigate the complexity of anaphylaxis coding, including the use of extensions and modifiers to reflect the clinical scenario accurately.
- Appreciate the importance of accurate anaphylaxis coding for patient care quality, safety, research, and healthcare reimbursement.
David M. Fleischer, MD, FACAAI (Moderator)
Children's Hospital Colorado
Dr. David Fleischer completed his undergraduate training at the University of Pennsylvania, medical degree training at Emory University School of Medicine, and both Pediatric Residency and Pediatric Allergy/Immunology Fellowship training at The Johns Hopkins University School of Medicine. Dr. Fleischer is currently the Section Head of Allergy & Immunology at Children’s Hospital Colorado (CHCO) and a Professor of Pediatrics at CHCO and the University of Colorado Denver School of Medicine. He is the Director of the Allergy and Immunology Center at CHCO. Dr. Fleischer is a nationally and internationally renowned food allergy expert, specializing in the diagnosis, management, and prevention of food allergy. His clinical research has focused on the natural history and novel treatments of food allergy, including oral, sublingual, and epicutaneous immunotherapies. He is the Global PI for several Phase III peanut epicutaneous immunotherapy trials that are being conducted at more than 30 sites across the world. He has authored many original, peer-reviewed articles, review articles, and book chapters on food allergy and food allergy treatment.
Anna Nowak-Wegrzyn, MD, PhD, FACAAI (Presenter)
NYU R. Grossman School of Medicine
Pediatric Allergy and Immunology, Hassenfeld Children's Hospital
Anna Nowak-Wegrzyn, M.D., PhD, FAAAAI, FACAAI, is a Professor of Pediatrics at the NYU Grossman School of Medicine, and the Director of the Pediatric Allergy and Immunology Division, Department of Pediatrics, the Hassenfeld Children’s Hospital, New York, NY. Her research interests focus on baked milk and baked egg diets, food-induced anaphylaxis in children, novel diagnostic and therapeutic approaches to food allergy (OIT, SLIT, EPIT), oral tolerance, and FPIES. She served as a director of the ABAI, 2017-2022 and AAAAI, 2022-. She is the Associate Editor for the Annals of Allergy, Asthma and Immunology, the official journal of the ACAAI.
J. Wesley Sublett, MD, MPH, FACAAI (Presenter and Resource Development)
Family Allergy & Asthma
Wes Sublett, MD, MPH, is a partner and medical director of clinical research at Family Allergy & Asthma, based in Louisville, Kentucky. He is a graduate of Saint Louis University (MPH) and the University of Louisville School of Medicine. Board certified in both pediatrics and allergy/immunology, Dr. Sublett completed his internship and residency in pediatrics at the University of Louisville – Kosair Children’s Hospital. He completed his fellowship in allergy, asthma, and immunology at the University of Cincinnati. He played a crucial role in getting a Kentucky House Bill passed that allows schools to purchase and store epinephrine auto-injectors and use them on children who fall into a life-threatening anaphylactic shock. Dr. Wes was present when Governor Beshear signed the bill into law in 2013. In addition, Dr. Wes is the Medical Director of the Family Allergy & Asthma Research Institute.
Theresa Bingemann, MD (Resource Development)
Professor of Pediatrics and Medicine
University of Rochester
Dr. Theresa Bingemann attended Rutgers University and earned her medical degree at the University of Medicine and Dentistry of New Jersey – New Jersey Medical School (Rutgers Medical School). She then completed a combined Internal Medicine-Pediatrics residency at Mount Sinai Hospital. Subsequently, she completed her Allergy and Immunology fellowship at the Mayo Clinic. Dr. Bingemann is a Professor of Pediatrics and Medicine at the University of Rochester where she is the Program Director for the Allergy and Immunology fellowship. She is actively involved in fellow, resident and medical student teaching. Dr. Bingemann is a Fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI), American College of Allergy, Asthma and Immunology (ACAAI), and the American Academy of Pediatrics. She serves on the editorial board of the Annals of Allergy, Asthma and Immunology and as a reviewer for several other journals.
Michael Pistiner, MD, MMSc (Resource Development)
Director of Food Allergy Advocacy, Education and Prevention
MassGeneral Hospital for Children, Food Allergy Center
Michael Pistiner, MD, MMSc has a special interests in food allergy and anaphylaxis education and advocacy, infant food allergy management, healthcare provider education, facilitating collaborations between the medical home and school health, and maintaining quality of life in children (and their families) with food allergies. Dr. Pistiner is a fellow in the American Academy of Pediatrics (AAP), where he is a member of the Section on Allergy and Immunology Executive Committee, Council on School Health and the Massachusetts Chapter of the AAP. He is also a member of the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma and Immunology. Additionally, he serves on the medical advisory board of Asthma & Allergy Foundation of America, New England Chapter and is a voluntary consultant for the Massachusetts Department of Public Health School Health Service Unit.